Tirofiban hydrochloride monohydrate
SIGMA/SML0246 - ≥98% (HPLC)
Synonym: L 700462; MK 383; N-
CAS Number: 150915-40-5
Empirical Formula (Hill Notation): C22H36N2O5S·HCl·H2O
Molecular Weight: 495.07
MDL Number: MFCD07368623
Linear Formula: C22H36N2O5S·HCl·H2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C22H36N2O5S.ClH.H2O/c1 |
| InChI key | HWAAPJPFZPHHBC-FGJQBABTSA |
| optical activity | [α]/D -10 to -18° (c=1, MeOH) |
| Quality Level | 100 ![]() |
| shipped in | wet ice |
| SMILES string | OC([C@@H](NS(CCCC)(=O)=O) |
| solubility | DMSO: >12 mg/mL at warmed to 60 °C |
| storage condition | desiccated |
| storage temp. | −20°C |
| Application: | Tirofiban hydrochloride monohydrate has been used as an αIIbβ3 integrin (glycoprotein IIb/IIIa) inhibitor for mouse induced pluripotent stem cell (iPSC) culture. |
| Biochem/physiol Actions: | Tirofiban hydrochloride is a potent non-peptide, glycoprotein IIb/IIIa inhibitor. Blocks platelet aggregation and thrombus formation. |
| Biochem/physiol Actions: | Tirofiban hydrochloride monohydrate is an αIIbβIII integrin inhibitor and an anticoagulant |
| Biochem/physiol Actions: | Tirofiban might cause thrombocytopenia. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-37-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


